University, Subject, Country, Region, World

GlaxoSmithKline Scientist and University Rankings 2022

AD Scientific Index - Scientist Rankings - 2022 H INDEX i10 INDEX CITATION
University unfold_more Country unfold_more Region unfold_more World unfold_more Name unfold_more Country unfold_more University unfold_more Subject unfold_more Total unfold_more Last 5 year unfold_more Last 5 year/total unfold_more Total unfold_more Last 5 year unfold_more Last 5 year/total unfold_more Total unfold_more Last 5 year unfold_more Last 5 year/total unfold_more
1 89 344 1040
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines|infectious diseases|vaccinology|global health|

149 79 0.530 706 417 0.591 86418 24494 0.283
2 136 478 1541
United Kingdom GlaxoSmithKline GlaxoSmithKline Candel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam

immunology|oncology|rheumatology|internal medicine|

135 78 0.578 561 433 0.772 79723 32704 0.410
3 455 1479 4908
United Kingdom GlaxoSmithKline GlaxoSmithKline SOUTHAMPTON and GSK

103 54 0.524 321 190 0.592 46001 12306 0.268
4 575 1863 6255
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Vaccines|adjuvants|RNA vaccines|LNP|

97 46 0.474 278 157 0.565 26912 7443 0.277
5 989 3225 10608
United Kingdom GlaxoSmithKline GlaxoSmithKline VP and Head of Experimental Medicine, GSK

immunology|renal medicine|

84 37 0.440 108 106 0.981 26432 6840 0.259
6 1132 3731 12206
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines|pathogenesis|

81 41 0.506 171 167 0.977 23624 6743 0.285
7 1146 3786 12370
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Cancer Genomics|

80 78 0.975 105 106 1.010 59015 51833 0.878
8 1315 4328 14090
United Kingdom GlaxoSmithKline GlaxoSmithKline Director of GSK Vaccines Institute for Global Health

Vaccines|public health|

78 37 0.474 126 122 0.968 20132 4864 0.242
9 1409 4601 14914
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

76 62 0.816 119 100 0.840 48455 21397 0.442
10 2546 8905 27775
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithkline

Epigenetics|

63 51 0.810 113 113 1.000 17780 9905 0.557
11 2807 9858 30461
United Kingdom GlaxoSmithKline GlaxoSmithKline Research Director for GlaxoSmithKline

drug discovery|

61 29 0.475 50 50 1.000 18097 2608 0.144
12 2858 10054 30986
United Kingdom GlaxoSmithKline GlaxoSmithKline Professor

Respiratory disease|

61 33 0.541 61 61 1.000 14043 4625 0.329
13 2925 10382 31875
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Immunology|Epigenetics|

60 36 0.600 69 69 1.000 19577 4494 0.230
14 3205 11484 35127
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome/GlaxoSmithKline R&D

Drug Discovery|Chemical Biology|Proteomics|Kinases|

58 44 0.759 80 79 0.988 27296 8880 0.325
15 3354 12095 37058
United Kingdom GlaxoSmithKline GlaxoSmithKline glaxosmithkline

57 30 0.526 99 95 0.960 21642 4650 0.215
16 3374 12137 37195
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome, a GSK company

Proteomics|Chemical Biologý|

57 48 0.842 78 77 0.987 18041 10636 0.590
17 3564 12887 39312
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines R&D

virology - vaccinology|

56 39 0.696 128 127 0.992 15553 9146 0.588
18 3736 13618 41360
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

55 25 0.455 44 42 0.955 15873 2356 0.148
19 4087 15068 45587
United Kingdom GlaxoSmithKline GlaxoSmithKline Computational Chemist, GlaxoSmithKline

Drug Discovery|Drug Design|

53 33 0.623 49 49 1.000 23926 3973 0.166
20 4842 18291 54885
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, Univeristy of Edinburgh, University Brunel

50 23 0.460 38 38 1.000 9591 2773 0.289
21 5138 19525 58175
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Cancer|infectious disease|vaccines|cell and gene therapy|

49 27 0.551 52 52 1.000 8679 2550 0.294
22 5477 21224 62830
United Kingdom GlaxoSmithKline GlaxoSmithKline

Mass Spectrometry|Proteomics|Phosphorylation|

47 22 0.468 39 39 1.000 14998 3279 0.219
23 5551 21480 63578
United Kingdom GlaxoSmithKline GlaxoSmithKline

Vaccine Malaria|

47 23 0.489 47 47 1.000 9957 2503 0.251
24 5788 22592 66683
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Chemokines|Cytokines|Immunology|receptors|

46 16 0.348 22 23 1.045 11268 1089 0.097
25 6082 23947 70430
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Pharmacolgy|

45 21 0.467 43 43 1.000 10883 1815 0.167
26 6473 25739 75234
United Kingdom GlaxoSmithKline GlaxoSmithKline VP & Head, Clinical R&D and Medical Affairs Latin America and the Caribbean

Vaccines|Infectious Disease|Pediatrics|Tropical Medicine & Parasitolgy|

44 24 0.545 53 52 0.981 8357 2258 0.270
27 6672 26810 78078
United Kingdom GlaxoSmithKline GlaxoSmithKline Computational Biologist, GSK

Bioinformatics|Cancer Genetics|Big Data|HPC|Drug Discovery|

43 31 0.721 47 47 1.000 21258 6491 0.305
28 6731 27028 78798
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Lupus|rheumatology|pregnancy|antiphospholipid syndrome|Sjogren's syndrome|

43 30 0.698 70 65 0.929 9993 4595 0.460
29 7379 30324 87757
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Molecular Biology|Genetics|Genomics|Transcriptomics|Yeast|

41 18 0.439 27 26 0.963 11653 1368 0.117
30 7410 30437 88085
United Kingdom GlaxoSmithKline GlaxoSmithKline Sr. Investigator, GlaxoSmithKline Pharmaceuticals

Bioinformatics|Text mining|Compuattional Biology|Drug Repositioning|

41 29 0.707 103 90 0.874 9536 4872 0.511
31 7518 30830 89226
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK, LSHTM, NYU

Pharmacovigilance|Pharmacoepidemiology|Data Mining|Clinical Pharmacology|Drug Safety|

41 29 0.707 54 54 1.000 7188 3024 0.421
32 7519 30839 89250
United Kingdom GlaxoSmithKline GlaxoSmithKline Director Preclinical Evidence Generation, Preclinical R&D, GSK Vaccines, Rockville MD

immunology|vaccine|host-pathogen interaction|

41 27 0.659 52 51 0.981 7168 2834 0.395
33 7759 32129 92595
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline Pharmaceuticals

Drug discovery|Cell biology|Renal and cardiovascular disease|

40 27 0.675 37 37 1.000 19632 3248 0.165
34 7776 32214 92854
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

40 35 0.875 58 57 0.983 12002 6851 0.571
35 8102 33798 97154
United Kingdom GlaxoSmithKline GlaxoSmithKline Real-World Evidence & Epidemiology, GSK

Epidemiology|

40 23 0.575 40 39 0.975 5023 1512 0.301
36 8156 34176 98092
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, Collegeville

Bioinformatics|Cancer Biology|Big Data|Cloud Computing|

39 31 0.795 42 42 1.000 20524 8311 0.405
37 8171 34224 98260
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Cancer cell biology|Tumor cell signaling|Synthetic Lethality|

39 23 0.590 31 31 1.000 13443 2163 0.161
38 8324 34899 100262
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Infectious diseases. Parasitology. Drug Discovery.Molecular Biology. Biochemistry. Genetics. Malaria|

39 32 0.821 61 61 1.000 6446 3764 0.584
39 8591 36360 104009
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

bioinformatics|epigenomics|transcriptomics|adipogenesis|obesity|

38 31 0.816 52 51 0.981 14550 8432 0.580
40 9259 39636 113152
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines|Structural Mass Spectrometry|Proteomics|

37 28 0.757 46 44 0.957 5423 1875 0.346
41 9609 41413 118048
United Kingdom GlaxoSmithKline GlaxoSmithKline Senior Fellow and Director, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline

Pharmacokinetics|Clinical Pharmacology|Drug Development|

36 24 0.667 44 43 0.977 6556 2974 0.454
42 9643 41558 118523
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Drug Discovery|

36 18 0.500 32 31 0.969 6054 1195 0.197
43 9652 41583 118599
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Biologia|Microbiologia|Biochimica|

36 23 0.639 44 44 1.000 5987 1948 0.325
44 9676 41687 118917
United Kingdom GlaxoSmithKline GlaxoSmithKline Sr Scientist, GSK Vaccines

Molecular Microbiology|

36 20 0.556 37 36 0.973 5746 1438 0.250
45 9732 41894 119480
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

biostatistics|

36 22 0.611 38 38 1.000 5379 1786 0.332
46 9985 43491 123608
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

36 27 0.750 52 49 0.942 3227 2094 0.649
47 9996 43550 123797
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

35 21 0.600 29 29 1.000 16223 2923 0.180
48 10014 43618 123987
United Kingdom GlaxoSmithKline GlaxoSmithKline Associate GSK Fellow, GSK Stevenage

BioTech|Molecular Biology Protein evolution|

35 27 0.771 41 41 1.000 11403 2987 0.262
49 10243 44642 126916
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Systems Biology|Transcriptomics|Gene Expression|Genomics|Bioinformatics|

35 24 0.686 38 38 1.000 4984 1877 0.377
50 10612 46628 132067
United Kingdom GlaxoSmithKline GlaxoSmithKline

Epigenetics|Oncology|

34 25 0.735 37 36 0.973 7630 4521 0.593
51 10750 47237 133868
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator, GSK

DMPK|

34 27 0.794 52 59 1.135 5191 2789 0.537
52 10970 48388 136987
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

genetic toxicology|photo-safety|mutagens|carcinogens|non-clinical safety|

34 18 0.529 28 28 1.000 3947 1023 0.259
53 11223 49819 140674
United Kingdom GlaxoSmithKline GlaxoSmithKline Head of FACS Facility, Preclinical R&D, GSK Vaccines, Rockville, MD

flow cytometry|immunology|vaccines|

33 19 0.576 26 26 1.000 6394 1381 0.216
54 11292 50062 141375
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithkline

structure biology|

33 19 0.576 31 31 1.000 5501 1476 0.268
55 11749 52719 148402
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

statistics|genetics|

32 18 0.563 43 30 0.698 11537 2421 0.210
56 12420 56261 158180
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Protein Crystallography|

31 24 0.774 31 31 1.000 8458 1705 0.202
57 12457 56400 158624
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Medicinal chemistry|Fragments|chemical biology|drug discovery|

31 22 0.710 30 30 1.000 6704 2290 0.342
58 12506 56520 158989
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator, GlaxoSmithKline

Onco immunology|

31 22 0.710 39 447 11.462 5938 2180 0.367
59 12530 56616 159276
United Kingdom GlaxoSmithKline GlaxoSmithKline Natural Sciences / Molecular Biology & Genetics

genetics|

31 29 0.935 40 40 1.000 5546 3926 0.708
60 12593 56889 160021
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

DNA Sequencing|

31 16 0.516 21 21 1.000 4885 1076 0.220
61 13128 59916 167989
United Kingdom GlaxoSmithKline GlaxoSmithKline Oncology, Data Strategy & Design Director at GSK

Data Mining|Cancer Biology|Early Target Discovery|

30 28 0.933 39 39 1.000 12846 9626 0.749
62 13143 59968 168158
United Kingdom GlaxoSmithKline GlaxoSmithKline Head of Bioimaging, GlaxoSmithKline

metabolomics|toxicology|imaging|

30 16 0.533 25 23 0.920 9632 4766 0.495
63 13210 60194 168832
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

30 19 0.633 31 29 0.935 6279 3167 0.504
64 13218 60210 168910
United Kingdom GlaxoSmithKline GlaxoSmithKline glaxosmithkline

Toxicology|Pathology|

30 20 0.667 32 31 0.969 6114 2118 0.346
65 13492 61428 172383
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline and the UNC HIV Cure Center

HIV|

30 18 0.600 28 28 1.000 3754 1129 0.301
66 13926 63964 178956
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

29 18 0.621 24 23 0.958 11043 4619 0.418
67 14029 64313 180073
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Genomics|NGS|Vitamin D|

29 20 0.690 28 27 0.964 5285 2871 0.543
68 14086 64543 180855
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Gene Therapy|Immuno-Oncology|Dermatology|Tissue repair|

29 22 0.759 37 36 0.973 4542 2376 0.523
69 14120 64688 181278
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

29 16 0.552 19 19 1.000 4251 1240 0.292
70 14154 64862 181800
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

29 16 0.552 20 20 1.000 4007 1471 0.367
71 14399 66038 185062
United Kingdom GlaxoSmithKline GlaxoSmithKline Cellzome, a GSK company

Spatial Omics|Multiomics|Cancer|Computer Vision|Deep Learning|

29 23 0.793 31 30 0.968 3125 1725 0.552
72 14687 68016 190408
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Statistical genetics|genetic epidemiology|genetics|bioinformatics|

28 24 0.857 32 31 0.969 8010 5901 0.737
73 14720 68170 190958
United Kingdom GlaxoSmithKline GlaxoSmithKline Cincinnati Children's Hospital Medical Center

Bioinformatics|Computational biology|Drug Discovery|

28 20 0.714 42 32 0.762 5775 3568 0.618
74 14820 68576 192140
United Kingdom GlaxoSmithKline GlaxoSmithKline Agenus

computational biology/chemistry|target tractability|antibody design|directed evolution|protein engineering|

28 19 0.679 36 25 0.694 4360 1237 0.284
75 14866 68751 192615
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

drug discovery|

28 18 0.643 28 26 0.929 4060 2563 0.631
76 15191 70563 197386
United Kingdom GlaxoSmithKline GlaxoSmithKline

oncology|immunology|animal models|

28 10 0.357 11 10 0.909 2872 392 0.136
77 15526 72742 203092
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

cancer|immunotherapy|cell therapy|gene therapy|GBM|

27 25 0.926 31 31 1.000 7505 4553 0.607
78 15763 73719 206014
United Kingdom GlaxoSmithKline GlaxoSmithKline Investigator

microbiology|

27 21 0.778 32 50 1.563 3599 1389 0.386
79 15964 74750 208833
United Kingdom GlaxoSmithKline GlaxoSmithKline Scientific Director, GSK

Drug discovery|pharmacology|mathematical modelling|

27 21 0.778 42 40 0.952 2933 2097 0.715
80 16034 75155 209892
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Medicinal Chemistry and Infectious Disease|

27 11 0.407 53 12 0.226 2775 920 0.332
81 16215 76498 213311
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

Computational Chemistry|

27 25 0.926 35 35 1.000 2363 1562 0.661
82 16272 76942 214493
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

medicinal chemistry|

27 19 0.704 25 23 0.920 2211 928 0.420
83 16367 77814 216699
United Kingdom GlaxoSmithKline GlaxoSmithKline Chief Computational Biologist, BioInfi

Computational Biology|Bioinformatics|Drug Discovery|Target Identification|Drug Repositioning|

26 18 0.692 30 30 1.000 11788 2829 0.240
84 16388 77880 216968
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

statistical genetics|genetics of immune-mediated diseases|

26 25 0.962 29 28 0.966 7598 6474 0.852
85 16416 77993 217380
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

Oncology|Functional Genomics|

26 22 0.846 36 31 0.861 5692 4009 0.704
86 16530 78411 218742
United Kingdom GlaxoSmithKline GlaxoSmithKline Pharma

Immuno-inflammation|

26 19 0.731 22 21 0.955 4033 1889 0.468
87 16590 78685 219496
United Kingdom GlaxoSmithKline GlaxoSmithKline Glaxo Smith Kline

26 23 0.885 34 31 0.912 3615 1690 0.467
88 16601 78754 219691
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK

PI3K|Kinases|Proteases|metalloproteinases|

26 15 0.577 21 21 1.000 3536 860 0.243
89 16825 79822 222699
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

clinical research|

26 19 0.731 23 23 1.000 2833 1010 0.357
90 17021 81027 225879
United Kingdom GlaxoSmithKline GlaxoSmithKline Group Leader Computational Mass Spectrometry Cellzome - GSK

Data engineering|Computational Biology|ROS|Proteostasis|

26 21 0.808 37 32 0.865 2418 1322 0.547
91 17178 82238 229081
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline Inc

26 12 0.462 16 16 1.000 2075 359 0.173
92 17179 82244 229093
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline R&D

Immunology|

26 16 0.615 24 23 0.958 2074 780 0.376
93 17272 83188 231601
United Kingdom GlaxoSmithKline GlaxoSmithKline Cell & Gene Therapy - Clinical Development, GSK

Immunotherapy|Cell therapy|Urothelial carcinoma|Renal cell carcinoma|PD-L1|

25 17 0.680 26 25 0.962 16088 12835 0.798
94 17409 83797 233705
United Kingdom GlaxoSmithKline GlaxoSmithKline Director, HIV Cure- ViiV Healthcare; Adj Asst Prof, UNC

HIV Cure|HIV Immunopathogenesis|Mucosal Immunology|Drug Discovery|

25 16 0.640 25 24 0.960 3834 1505 0.393
95 17535 84361 235300
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, GSK

biopharmaceutics|dissolution|drug delivery|

25 23 0.920 34 30 0.882 3159 1768 0.560
96 17614 84743 236387
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline, North Dakota Sate, University of Utah

chemistry|drug metabolism|spectrscopy|NMR|MALDI|

25 17 0.680 23 23 1.000 2895 1009 0.349
97 17625 84830 236604
United Kingdom GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline

25 13 0.520 20 19 0.950 2855 645 0.226
98 18056 87712 244159
United Kingdom GlaxoSmithKline GlaxoSmithKline Development Scientist at GSK

Chemistry|Mass Spectrometry|Infrared Spectroscopy|

25 17 0.680 24 24 1.000 2008 697 0.347
99 18102 88028 244995
United Kingdom GlaxoSmithKline GlaxoSmithKline FLI DPU, GlaxoSmithKline

Pharmacology|Receptor Theory|GPCRs|Allosteric modulation|

25 13 0.520 16 15 0.938 1928 470 0.244
100 18499 90348 251462
United Kingdom GlaxoSmithKline GlaxoSmithKline GSK Vaccines

Vaccines|Molecular biology|Genomics|

24 21 0.875 28 26 0.929 3052 1206 0.395